Security key
152309100
Centessa Pharmaceuticals plc - Ordinary Shares, nominal value GBP 0.002 per share (CNTA)
CUSIP: 152309100
Q1 2026 13F Holders as of 31 Mar 2026
- Security type / class
- Equity / Ordinary Shares, nominal value GBP 0.002 per share
- Shares outstanding
- 154,150,943
- Total 13F shares
- 148,632,709
- Share change
- +4,874,750
- Total reported value
- $5,896,478,651
- Put/Call ratio
- 63%
- Reported price per share
- $39.72
- Number of holders
- 160
- Value change
- +$329,840,050
- Number of buys
- 97
- Number of sells
- 77
Security identity
Holder snapshot
Report period
Q1 2026
Institutions
160
Top holders
10
CNTA full security history
Ownership snapshot
Full 13F holder table
Previous quarter: Q4 2025
Centessa Pharmaceuticals plc SEC filings
Centessa Pharmaceuticals plc company facts
Broader feeds
Reporting periods
Holder history for CUSIP 152309100
Recent filing periods:
Ownership snapshot
Top reported holders of CNTA - Centessa Pharmaceuticals plc - Ordinary Shares, nominal value GBP 0.002 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Lead holder
FMR LLC
13D/G signal
FMR LLC
Evidence rows
15
Latest as of
31 Mar 2026
13D/G
13F
3/4/5
Lead comparable stake: 7.5%
13D/G row: FMR LLC
Showing 1-6 of 15 holder rows.
Rank 1 holder
FMR LLC
13D/G
13F
- Ownership
- 7.5%
- Position
- $268.41M
Rank 2 holder
Avoro Capital Advisors LLC
13D/G
13F
- Ownership
- 7.4%
- Position
- $452.3M
Rank 3 holder
Adage Capital Management, L.P.
13D/G
- Ownership
- 5.8%
- Position
- $353.16M
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| FMR LLC |
13D/G
13F
Company
|
7.5%
|
$268,405,170
6,783,047 shares
|
-$166,856,639 | 31 Mar 2026 |
| Avoro Capital Advisors LLC |
13D/G
13F
Company
|
7.4%
|
$452,303,104
11,430,455 shares
|
-$123,660,207 | 31 Mar 2026 |
| Adage Capital Management, L.P. |
13D/G
|
5.8%
|
$353,162,646
8,925,010 shares
|
-$43,922,304 | 31 Mar 2026 |
| Pentwater Capital Management LP |
13D/G
|
5.3%
|
$323,286,900
8,170,000 shares
|
$0 | 31 Mar 2026 |
| General Atlantic Cooperatief U.A. |
13D/G
|
5%
|
$180,192,368
7,366,818 shares
|
-$56,624,900 | 25 Nov 2025 |
| Medicxi Ventures Management (Jersey) Ltd |
13F
3/4/5
Company · 10%+ Owner
|
13%
|
$499,278,557
19,963,157 shares
|
— | 31 Dec 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
160
Shares
148,632,709
Rows available
160
| Investor | Option | Weight % | Change % | Reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that failed the local validity check.
Compare Q1 2026 vs Q4 2025 Across Filers
Q4 2025 holders
147
Q1 2026 holders
160
Holder diff
13
| Investor | Q4 2025 Shares | Q1 2026 Shares | Share Diff | Share Chg % | Q4 2025 value | Q1 2026 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend